SPC298

Dróspírenón

  • Status:
    Umsókn
  • Application date:
    10.6.2020
  • Application published:
    15.7.2020
  • Max expiry date:
    21.10.2034
  • Medicine name:
    Slinda
  • Medicine for children:
    No

Timeline

Today
10.6.2020Application
15.7.2020Publication
21.10.2034Expires

Marketing license

  • IS authorization number:
    IS/1/19/084/01
  • Date:
    15.1.2020
  • Foreign authorization number:
    61678
  • Date:
    16.10.2019

Owner

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents